Saudi Journal of Kidney Diseases and Transplantation

RENAL DATA FROM THE ASIA - AFRICA
Year
: 2010  |  Volume : 21  |  Issue : 2  |  Page : 363--367

Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran


Nariman Sepehrvand1, Zakieh Rostamzadeh Khameneh2, Hamid-Reza Farrokh Eslamloo3 
1 Student's Research Committee, Urmia University of Medical Sciences, Urmia, Iran
2 Department of Microbiology, School of Paramedicine, Urmia University of Medical Sciences, Urmia, Iran
3 Department of Public Health, Urmia University of Medical Sciences, Urmia, Iran

Correspondence Address:
Zakieh Rostamzadeh Khameneh
Department of Microbiology, School of Paramedicine, Urmia University of Medical Sciences, Urmia, West-Azerbaijan
Iran

Cytomegalovirus (CMV) causes infection in immunocompromised, transplant reci­pients and those who received blood transfusion frequently. Risk factors for primary CMV infec­tion are blood transfusion (including clotting factors, etc), recipients of infected transplants, hemo­dialysis and the frequency of dialysis in a week. This study aimed at determining the prevalence of cytomegalovirus (CMV) antibodies in end-stage renal disease (ESRD) patients who undergo hemodialysis. A cross-sectional study of hemodialysis patients in Urmia, Iran was undertaken in 2007. Sera of 84 Hemodialysis patients were investigated for CMV-specific immunoglobulin G (IgG). Forty-four (52%) patients were males. 65 patients (77.4%) were anti-CMV IgG positive and 6 (7.1%) were anti-CMV IgM positive. There was no relationship between the antibody titer and dialysis duration, or frequency of HD in a week. In conclusion, we recommend that every patient who has undergone hemodialysis receive blood products free of CMV if CMV negative to reduce the incidence and prevalence of CMV among HD patients.


How to cite this article:
Sepehrvand N, Khameneh ZR, Eslamloo HRF. Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran.Saudi J Kidney Dis Transpl 2010;21:363-367


How to cite this URL:
Sepehrvand N, Khameneh ZR, Eslamloo HRF. Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran. Saudi J Kidney Dis Transpl [serial online] 2010 [cited 2020 Sep 19 ];21:363-367
Available from: http://www.sjkdt.org/article.asp?issn=1319-2442;year=2010;volume=21;issue=2;spage=363;epage=367;aulast=Sepehrvand;type=0